Navigation Links
Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum
Date:12/9/2009

Opinion Leaders Examine the Role of the Sciences in Education over the Next Decade

WASHINGTON, Dec. 9 /PRNewswire-USNewswire/ -- On Tuesday, December 8, 2009, Scientific American, the longest continuously published magazine in the U.S., hosted The Decade-2 Education Forum in Washington, D.C. The forum was organized to promote the teaching of math and science to America's students and was sponsored by Amgen, a leading biotechnology company committed to science education in the U.S.

Building upon recent national initiatives such as President Obama's "Educate to Innovate" campaign and his $4.35 billion "Race to the Top" school competition, Scientific American assembled prominent thinkers and leaders before an audience of more than 100 education advocates from government, industry and academia. The participants actively debated the question "Are we at a crossroads in defining the role and scope of a quality science education for all students?"

Presenting attendees included Tony Miller, U.S. Department of Education deputy secretary; Kristina Johnson, U.S. Department of Energy undersecretary; House Science and Technology Committee Chairman The Honorable Bart Gordon (D-TN); the Honorable Sherwood Boehlert (R-NY), former Chairman of the House Science and Technology Committee; Eugenie Scott, executive director, National Center for Science; Robert M. Lippincott, senior vice president, Education, PBS; and Craig Robinson, Ph.D., executive director, National Science Foundation, among others.

"In recent months we have seen fresh thinking about the future of technology, innovation and how best to inspire a new generation of students," said Bruce Brandfon, publisher, Scientific American. "This forum proved to be an informative and insightful assembly of persons vested in the success of the American education system, and consequently, the success of America."

Several key themes emerged during the day's discussions:

  • The state of tomorrow's workforce: over the next five years 40-50% of the U.S. workforce will retire.
  • The state of the classroom: The U.S. is lagging behind several other countries in academics, and coupled with the fact that only 18% of U.S. high school students can pass a science proficiency test it is clear that something must be done to address what will be a drastic shortage of scientists in our country.
  • Finding solutions for building an effective workforce of scientists who can solve our most difficult technological challenges by inspiring U.S. students to purse science careers. These solutions included public policy solutions, alignment of academic standards, federal funding, curriculum innovation and educator training.

To view video highlights of Kristina Johnson keynote address, please click HERE.

"Amgen is proud to be a part of today's important dialogue," said Joe Miletich, senior vice president of Research and Development at Amgen. "Amgen, and other companies on the cutting edge of biotechnology, depend on the ingenuity and pioneering spirit of new generations of Americans. We are committed to supporting education programs that entice and encourage students to explore their future in science."

About Scientific American

Scientific American is at the heart of Nature Publishing Group's (www.nature.com) newly formed consumer media division, which focuses on the needs of the general public. Founded in 1845, Scientific American (www.scientificamerican.com) is the longest continuously published magazine in the U.S. and the premier science publication in consumer media.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

SOURCE Scientific American


'/>"/>
SOURCE Scientific American
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
7. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
8. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
9. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... Services portfolio to include an array of biochemical analyses critical for Lead ... to drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced ... for two key immunotherapy technologies from the University ... provides a method to monitor a patient for ... PD-L1 and CTLA-4.  The second license extends the ... patient is likely to have an immune-related adverse ...
(Date:2/23/2017)... , Feb. 23, 2017  Seattle,s upscale Capitol Hill ... a strange place for a head lice treatment salon to ... between a Tuscan restaurant and a French bistro on E ... perfect. "We aren,t just any old lice clinic, we pride ... feel comfortable, and release some of the stigma associated with ...
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain ... for adults at home or in healthcare facilities during periods of rest. A ...
Breaking Biology Technology:
(Date:2/7/2017)... York , February 7, 2017 ... ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the ... and electronic transaction processing services, is pleased to announce ... the Company. Effective January 31, 2017, ... Board of Directors, CEO and President.  An experienced payment ...
(Date:2/3/2017)... Biomedical Research Institute announced that its Board of Trustees has ... Institute,s new President and CEO. Dr. Schlesinger will take the ... currently the Chair of the Department of Microbial Infection and ... at Ohio State University. "We are delighted to ... Texas Biomed," said Dr. James O. Rubin , Board ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):